Humana Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year) increased by 0.1% to $1.13B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.1%, from $988.00M to $1.13B. This is a positive signal — higher values indicate stronger performance for this metric.
Higher amounts indicate greater near-term liquidity and the ability to reinvest at current market rates, which is beneficial in rising rate environments.
This metric measures the amortized cost of available-for-sale debt securities that are scheduled to mature within one ye...
Commonly used to assess the maturity profile and liquidity of bank balance sheets.
afs_debt_securities_amortized_cost_1y| Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $500.00M | $561.00M | $1.24B | $1.39B | $1.08B | $988.00M | $854.00M | $1.13B | $1.13B |
| QoQ Change | — | +12.2% | +120.1% | +12.6% | -22.2% | -8.7% | -13.6% | +31.9% | +0.1% |
| YoY Change | — | — | +147.0% | +147.8% | — | -20.0% | -38.6% | +4.1% | +14.1% |